Ra Capital Healthcare Fund Lp - Net Worth and Insider Trading

Ra Capital Healthcare Fund Lp Net Worth

The estimated net worth of Ra Capital Healthcare Fund Lp is at least $4.4 Billion dollars as of 2024-11-05. Ra Capital Healthcare Fund Lp is the 10% Owner of Synthorx Inc and owns about 14,903,741 shares of Synthorx Inc (THOR) stock worth over $1.0 Billion. Ra Capital Healthcare Fund Lp is the Director, 10% Owner of Janux Therapeutics Inc and owns about 10,365,652 shares of Janux Therapeutics Inc (JANX) stock worth over $579 Million. Ra Capital Healthcare Fund Lp is also the 10% Owner of Vaxcyte Inc and owns about 5,001,593 shares of Vaxcyte Inc (PCVX) stock worth over $533 Million. Besides these, Ra Capital Healthcare Fund Lp also holds WAVE Life Sciences Ltd (WVE) , Eidos Therapeutics Inc (EIDX) , Ra Pharmaceuticals Inc (RARX) , Rhythm Pharmaceuticals Inc (RYTM) , Forma Therapeutics Holdings Inc (FMTX) , Bicara Therapeutics Inc (BCAX) , Septerna Inc (SEPN) , Icosavax Inc (ICVX) , Arvinas Inc (ARVN) , Achillion Pharmaceuticals Inc (ACHN) , Cytek Biosciences Inc (CTKB) , Phathom Pharmaceuticals Inc (PHAT) , G1 Therapeutics Inc (GTHX) , Acumen Pharmaceuticals Inc (ABOS) , LENZ Therapeutics Inc (LENZ) , Fulcrum Therapeutics Inc (FULC) , DICE Therapeutics Inc (DICE) , Akouos Inc (AKUS) , Solid Biosciences Inc (SLDB) , Imara Inc (IMRA) , Mineralys Therapeutics Inc (MLYS) , Orchard Therapeutics PLC (ORTX) , ARS Pharmaceuticals Inc (SPRY) , Therapeutics Acquisition Corp (RACA) , scPharmaceuticals Inc (SCPH) , Black Diamond Therapeutics Inc (BDTX) , Artiva Biotherapeutics Inc (ARTV) , Tyra Biosciences Inc (TYRA) , Elevance Health Inc (ANTX) , Satsuma Pharmaceuticals Inc (STSA) , Verastem Inc (VSTM) , Acrivon Therapeutics Inc (ACRV) , 89bio Inc (ETNB) , Climb Bio Inc (CLYM) , Nkarta Inc (NKTX) , Vor Biopharma Inc (VOR) , PepGen Inc (PEPG) , Werewolf Therapeutics Inc (HOWL) , Kala Bio Inc (KALA) , Boundless Bio Inc (BOLD) , Aerovate Therapeutics Inc (AVTE) , AN2 Therapeutics Inc (ANTX) . Details can be seen in Ra Capital Healthcare Fund Lp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ra Capital Healthcare Fund Lp has not made any transactions after 2024-10-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Ra Capital Healthcare Fund Lp

To

Ra Capital Healthcare Fund Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ra Capital Healthcare Fund Lp owns 56 companies in total, including Vaxcyte Inc (PCVX) , 89bio Inc (ETNB) , and Rhythm Pharmaceuticals Inc (RYTM) among others .

Click here to see the complete history of Ra Capital Healthcare Fund Lp’s form 4 insider trades.

Insider Ownership Summary of Ra Capital Healthcare Fund Lp

Ticker Comapny Transaction Date Type of Owner
PCVX Vaxcyte Inc 2020-10-08 10 percent owner
ETNB 89bio Inc 2024-03-04 director & 10 percent owner
RYTM Rhythm Pharmaceuticals Inc 2020-12-03 10 percent owner
LIMIT LIMIT 2020-06-30 10 percent owner
LIMIT LIMIT 2020-06-25 10 percent owner
LIMIT LIMIT 2020-06-23 10 percent owner
LIMIT LIMIT 2020-05-05 10 percent owner
LIMIT LIMIT 2020-04-02 director & 10 percent owner
LIMIT LIMIT 2021-03-11 10 percent owner
LIMIT LIMIT 2022-12-09 10 percent owner
LIMIT LIMIT 2022-05-26 director & 10 percent owner
LIMIT LIMIT 2021-03-15 10 percent owner
LIMIT LIMIT 2020-01-23 10 percent owner
LIMIT LIMIT 2021-02-26 director & 10 percent owner
LIMIT LIMIT 2018-10-23 10 percent owner
LIMIT LIMIT 2018-10-01 10 percent owner
LIMIT LIMIT 2018-06-22 10 percent owner
LIMIT LIMIT 2017-12-18 10 percent owner
LIMIT LIMIT 2017-05-22 10 percent owner
LIMIT LIMIT 2016-11-21 10 percent owner
LIMIT LIMIT 2015-10-22 10 percent owner
LIMIT LIMIT 2023-12-11 10 percent owner
LIMIT LIMIT 2014-09-29 other: Former 10% Owner & See FN(5)(6)
LIMIT LIMIT 2013-06-26 10 percent owner
LIMIT LIMIT 2014-01-10 other: Fmr 10% Owner - See Fn (1)-(5)
LIMIT LIMIT 2010-02-26 10 percent owner
LIMIT LIMIT 2008-10-29 10 percent owner
LIMIT LIMIT 2008-07-10 10 percent owner
LIMIT LIMIT 2007-08-08 10 percent owner
LIMIT LIMIT 2021-08-03 10 percent owner
LIMIT LIMIT 2023-07-21 director & 10 percent owner
LIMIT LIMIT 2020-12-07 10 percent owner
LIMIT LIMIT 2023-03-30 director & 10 percent owner
LIMIT LIMIT 2020-11-22 10 percent owner
LIMIT LIMIT 2024-01-11 director & 10 percent owner
LIMIT LIMIT 2020-09-24 10 percent owner
LIMIT LIMIT 2024-06-27 director & 10 percent owner
LIMIT LIMIT 2023-01-06 director & 10 percent owner
LIMIT LIMIT 2022-03-29 director & 10 percent owner
LIMIT LIMIT 2024-03-27 10 percent owner
LIMIT LIMIT 2024-06-17 director & 10 percent owner
LIMIT LIMIT 2021-04-01 10 percent owner
LIMIT LIMIT 2021-06-23 director
LIMIT LIMIT 2021-02-09 director & 10 percent owner
LIMIT LIMIT 2024-10-18 director & 10 percent owner
LIMIT LIMIT 2022-03-11 director
LIMIT LIMIT 2024-02-09 director & 10 percent owner
LIMIT LIMIT 2021-09-17 director & 10 percent owner
LIMIT LIMIT 2024-08-09 10 percent owner
LIMIT LIMIT 2023-01-20 10 percent owner
LIMIT LIMIT 2022-11-08 director
LIMIT LIMIT 2022-11-17 director & 10 percent owner
LIMIT LIMIT 2024-03-27 director
LIMIT LIMIT 2020-03-11 10 percent owner
LIMIT LIMIT 2023-02-14 director & 10 percent owner
LIMIT LIMIT 2023-07-05 director

Ra Capital Healthcare Fund Lp Latest Holdings Summary

Ra Capital Healthcare Fund Lp currently owns a total of 45 stocks. Among these stocks, Ra Capital Healthcare Fund Lp owns 14,903,741 shares of Synthorx Inc (THOR) as of December 11, 2018, with a value of $1.0 Billion and a weighting of 22.86%. Ra Capital Healthcare Fund Lp owns 10,365,652 shares of Janux Therapeutics Inc (JANX) as of October 18, 2024, with a value of $579 Million and a weighting of 13.07%. Ra Capital Healthcare Fund Lp also owns 5,001,593 shares of Vaxcyte Inc (PCVX) as of October 8, 2020, with a value of $533 Million and a weighting of 12.02%. The other 42 stocks WAVE Life Sciences Ltd (WVE) , Eidos Therapeutics Inc (EIDX) , Ra Pharmaceuticals Inc (RARX) , Rhythm Pharmaceuticals Inc (RYTM) , Forma Therapeutics Holdings Inc (FMTX) , Bicara Therapeutics Inc (BCAX) , Septerna Inc (SEPN) , Icosavax Inc (ICVX) , Arvinas Inc (ARVN) , Achillion Pharmaceuticals Inc (ACHN) , Cytek Biosciences Inc (CTKB) , Phathom Pharmaceuticals Inc (PHAT) , G1 Therapeutics Inc (GTHX) , Acumen Pharmaceuticals Inc (ABOS) , LENZ Therapeutics Inc (LENZ) , Fulcrum Therapeutics Inc (FULC) , DICE Therapeutics Inc (DICE) , Akouos Inc (AKUS) , Solid Biosciences Inc (SLDB) , Imara Inc (IMRA) , Mineralys Therapeutics Inc (MLYS) , Orchard Therapeutics PLC (ORTX) , ARS Pharmaceuticals Inc (SPRY) , Therapeutics Acquisition Corp (RACA) , scPharmaceuticals Inc (SCPH) , Black Diamond Therapeutics Inc (BDTX) , Artiva Biotherapeutics Inc (ARTV) , Tyra Biosciences Inc (TYRA) , Elevance Health Inc (ANTX) , Satsuma Pharmaceuticals Inc (STSA) , Verastem Inc (VSTM) , Acrivon Therapeutics Inc (ACRV) , 89bio Inc (ETNB) , Climb Bio Inc (CLYM) , Nkarta Inc (NKTX) , Vor Biopharma Inc (VOR) , PepGen Inc (PEPG) , Werewolf Therapeutics Inc (HOWL) , Kala Bio Inc (KALA) , Boundless Bio Inc (BOLD) , Aerovate Therapeutics Inc (AVTE) , AN2 Therapeutics Inc (ANTX) have a combined weighting of 52.05% among all his current holdings.

Latest Holdings of Ra Capital Healthcare Fund Lp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
THOR Synthorx Inc 2018-12-11 14,903,741 67.99 1,013,305,351
JANX Janux Therapeutics Inc 2024-10-18 10,365,652 55.87 579,128,977
PCVX Vaxcyte Inc 2020-10-08 5,001,593 106.49 532,619,639
WVE WAVE Life Sciences Ltd 2023-12-11 19,202,009 13.79 264,795,704
EIDX Eidos Therapeutics Inc 2018-06-22 2,162,671 122.21 264,300,023
RARX Ra Pharmaceuticals Inc 2018-12-12 4,858,260 47.99 233,147,897
RYTM Rhythm Pharmaceuticals Inc 2020-12-03 4,360,860 52.91 230,733,103
FMTX Forma Therapeutics Holdings Inc 2020-06-23 9,011,651 20.01 180,323,137
BCAX Bicara Therapeutics Inc 2024-09-16 6,955,993 25.14 174,838,884
SEPN Septerna Inc 2024-10-28 6,995,858 23.86 166,940,760
ICVX Icosavax Inc 2022-03-29 5,963,565 15.31 91,302,180
ARVN Arvinas Inc 2018-10-01 3,138,412 26.80 84,109,442
ACHN Achillion Pharmaceuticals Inc 2013-09-30 11,657,061 6.76 78,801,732
CTKB Cytek Biosciences Inc 2022-03-11 12,797,184 5.20 66,545,357
PHAT Phathom Pharmaceuticals Inc 2021-03-11 3,115,008 18.94 58,998,252
GTHX G1 Therapeutics Inc 2017-05-22 6,691,792 7.15 47,846,313
ABOS Acumen Pharmaceuticals Inc 2023-07-21 13,632,029 2.96 40,350,806
LENZ LENZ Therapeutics Inc 2024-03-21 1,389,510 28.74 39,934,517
FULC Fulcrum Therapeutics Inc 2023-01-20 11,609,704 3.26 37,847,635
DICE DICE Therapeutics Inc 2023-03-30 786,407 47.55 37,393,653
AKUS Akouos Inc 2020-06-30 2,281,249 13.29 30,317,799
SLDB Solid Biosciences Inc 2024-01-11 4,301,877 5.66 24,348,624
IMRA Imara Inc 2022-12-09 3,250,724 6.32 20,544,576
MLYS Mineralys Therapeutics Inc 2023-02-14 1,311,247 13.50 17,701,835
ORTX Orchard Therapeutics PLC 2020-09-24 988,087 16.70 16,501,053
SPRY ARS Pharmaceuticals Inc 2024-03-27 902,904 15.16 13,688,025
RACA Therapeutics Acquisition Corp 2021-06-29 1,098,318 10.27 11,284,449
SCPH scPharmaceuticals Inc 2021-03-15 2,727,446 4.03 10,991,607
BDTX Black Diamond Therapeutics Inc 2023-07-05 3,525,754 2.99 10,542,004
ARTV Artiva Biotherapeutics Inc 2024-07-22 826,832 11.45 9,467,226
TYRA Tyra Biosciences Inc 2021-09-17 442,721 16.30 7,216,352
ANTX Elevance Health Inc 2022-03-29 415,612 15.84 6,583,294
STSA Satsuma Pharmaceuticals Inc 2021-02-26 5,155,854 1.10 5,671,439
VSTM Verastem Inc 2020-06-25 1,345,170 3.78 5,084,743
ACRV Acrivon Therapeutics Inc 2022-11-17 426,302 7.76 3,308,104
ETNB 89bio Inc 2024-03-04 335,364 9.36 3,137,666
CLYM Climb Bio Inc 2024-06-27 841,087 3.51 2,952,215
NKTX Nkarta Inc 2024-03-27 754,311 3.23 2,436,425
VOR Vor Biopharma Inc 2021-02-09 1,825,326 0.78 1,423,754
PEPG PepGen Inc 2024-02-09 207,672 6.79 1,410,093
HOWL Werewolf Therapeutics Inc 2023-01-06 443,825 2.26 1,003,045
KALA Kala Bio Inc 2022-05-26 140,792 6.87 966,537
BOLD Boundless Bio Inc 2024-04-02 295,844 2.92 863,864
AVTE Aerovate Therapeutics Inc 2024-06-17 311,170 2.72 846,382
ANTX AN2 Therapeutics Inc 2024-08-09 300,853 1.08 324,921

Holding Weightings of Ra Capital Healthcare Fund Lp


Ra Capital Healthcare Fund Lp Form 4 Trading Tracker

According to the SEC Form 4 filings, Ra Capital Healthcare Fund Lp has made a total of 0 transactions in Synthorx Inc (THOR) over the past 5 years. The most-recent trade in Synthorx Inc is the acquisition of 4,545,455 shares on December 11, 2018, which cost Ra Capital Healthcare Fund Lp around $50 Million.

According to the SEC Form 4 filings, Ra Capital Healthcare Fund Lp has made a total of 2 transactions in Janux Therapeutics Inc (JANX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Janux Therapeutics Inc is the acquisition of 1,200,000 shares on October 18, 2024, which cost Ra Capital Healthcare Fund Lp around $54 Million.

According to the SEC Form 4 filings, Ra Capital Healthcare Fund Lp has made a total of 2 transactions in Vaxcyte Inc (PCVX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Vaxcyte Inc is the sale of 266,258 shares on October 8, 2020, which brought Ra Capital Healthcare Fund Lp around $14 Million.

More details on Ra Capital Healthcare Fund Lp's insider transactions can be found in the Insider Trading History of Ra Capital Healthcare Fund Lp table.

Insider Trading History of Ra Capital Healthcare Fund Lp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ra Capital Healthcare Fund Lp Trading Performance

GuruFocus tracks the stock performance after each of Ra Capital Healthcare Fund Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ra Capital Healthcare Fund Lp is 3.04%. GuruFocus also compares Ra Capital Healthcare Fund Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ra Capital Healthcare Fund Lp within 3 months outperforms 35 times out of 80 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ra Capital Healthcare Fund Lp's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ra Capital Healthcare Fund Lp

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
22 out of 64 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.67 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 6.2 LIMIT LIMIT LIMIT LIMIT LIMIT

Ra Capital Healthcare Fund Lp Ownership Network

Ownership Network List of Ra Capital Healthcare Fund Lp

No Data

Ownership Network Relation of Ra Capital Healthcare Fund Lp

Insider Network Chart

Ra Capital Healthcare Fund Lp Owned Company Details

What does Vaxcyte Inc do?

Who are the key executives at Vaxcyte Inc?

Ra Capital Healthcare Fund Lp is the 10 percent owner of Vaxcyte Inc. Other key executives at Vaxcyte Inc include Chief Operating Officer Jim Wassil , director & President & CEO Grant Pickering , and CFO & CBO Andrew Guggenhime .

Vaxcyte Inc (PCVX) Insider Trades Summary

Over the past 18 months, Ra Capital Healthcare Fund Lp made no insider transaction in Vaxcyte Inc (PCVX). Other recent insider transactions involving Vaxcyte Inc (PCVX) include a net sale of 268,266 shares made by Grant Pickering , a net sale of 152,000 shares made by Andrew Guggenhime , and a net sale of 66,000 shares made by Jim Wassil .

In summary, during the past 3 months, insiders sold 209,515 shares of Vaxcyte Inc (PCVX) in total and bought 0 shares, with a net sale of 209,515 shares. During the past 18 months, 598,563 shares of Vaxcyte Inc (PCVX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 598,563 shares.

Vaxcyte Inc (PCVX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Vaxcyte Inc Insider Transactions

No Available Data

Ra Capital Healthcare Fund Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Ra Capital Healthcare Fund Lp. You might contact Ra Capital Healthcare Fund Lp via mailing address: 200 Berkeley Street, 18th Floor, Boston Ma 02116.